Uncertainty in evaluating treatment outcomes in carbapenem-resistant Acinetobacter baumannii infections,Antimicrobial Agents and Chemotherapy

当前位置： X-MOL 学术 › Antimicrob. Agents Chemother. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Uncertainty in evaluating treatment outcomes in carbapenem-resistant Acinetobacter baumannii infections
Antimicrobial Agents and Chemotherapy ( IF 4.9 ) Pub Date : 2021-08-23 , DOI: 10.1128/aac.01424-21
Jessica Howard-Anderson ₁ , David van Duin ₂

Affiliation

Carbapenem-resistant Acinetobacter baumannii (CRAB) infections are challenging to treat and associated with poor clinical outcomes. In this issue, sulbactam-durlobactam, a novel β-lactam-β-lactamase inhibitor, was used with cefiderocol to successfully ...

中文翻译：